Optisure
Device Cardiac Rhythm Management
PDI 05414734507486
General payments
$29,175
Research payments
$101,514
Through program year 2024, $29,175 in general payments and $101,514 in research payments were reported against Optisure (Cardiac Rhythm Management).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $1,268 | 39 |
| 2023 | General | $1,802 | 74 |
| 2023 | Research | $46,702 | 3 |
| 2022 | General | $26,105 | 239 |
| 2022 | Research | $54,811 | 7 |
Breakdown
The top 5 of 31 recipients; each share is of general payments naming this product in 2024.
The top 5 of 11 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 11 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
352 general · 10 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.